Don't Wait for FDA Approval
Biotech stocks are booming in 2024, but picking winners is tough--most drugs face a decade-long FDA approval process. However, a special FDA signal has led to stock spikes 97% of the time. Now, I believe one drug company is on the verge of getting this FDA signal.
Financials
| Curr Year EPS Estimate | 18.45 |
| Next Quarter EPS Estimate | 6.14 |
| Profit Margin | 0.30 |
| Return on Assets | 0.11 |
| Return on Equity | 0.34 |
| Revenue | 13,444,599,808 |
| Earnings Per Share | 24.80 |
| Revenue Per Share | 83.56 |
| Gross Profit | 11,639,400,000 |
| Quarterly Revenue Growth | -0.22 |
General
| Name | Biogen Inc |
| Ticker | BIIB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers-General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 9,100 |
About Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB111 and BIIB112 to treat ophthalmology related diseases; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and TMS-007 to treat acute neurology; BIIB074 and BIIB095 for neuropathic pain; and SB11 and SB15 biosimilars, which are under various stages of development. The company offers products through its sales force and marketing groups. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; and Ionis Pharmaceuticals, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Earnings
SpaceX launches rescue mission for 2 NASA astronauts who are stuck in space until next year
CAPE CANAVERAL, Fla. (AP) — SpaceX for the two stuck astronauts at the International Space Station on Saturday, sending up a downsized crew to bring them home but not until next year.
Decoding Zuckerberg's Efficiency Mantra: A Wifi Password Speaks Volumes
Meta subtly hinted at CEO Mark Zuckerberg's ongoing commitment to efficiency with the WiFi password at a recent event.
Oil = Monthly Income - Ad
Right now, there's an unusual $25 way to collect MONTHLY income from the oil markets. It's not a stock, bond, or anything you've likely heard about... But it's by far my #1 investment opportunity for 2024.
Kennedy Campaign Rollercoaster: Wisconsin Supreme Court Keeps RFK Jr. On Swing State Ballot
Robert F. Kennedy Jr. will stay on Wisconsin's presidential ballot after a state Supreme Court ruling.
GOP Senator Rand Paul Proposes Tripling Hemp THC Cap, As Industry Faces Pressing Challenges
Senator Rand Paul's HEMP Act seeks to triple the hemp THC cap to 1%, easing regulations, aiming to boost growth for the U.S. hemp industry.
If You Wait for FDA Approval, It Could Be Too Late ... - Ad
Biotech stocks can be incredibly rewarding, but picking the right ones is nearly impossible without a PhD or insider knowledge. The FDA approval process is long and costly, and 9 out of 10 drugs never make it. However, a special FDA signal has led to stock spikes 97% of the time, regardless of approval.
Top 3 Energy Stocks That Could Lead To Your Biggest Gains This Month
The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
Experts Slam Trump's 200% Tariff Threat To John Deere: 'You'll Find No Serious, Respected Trade Economists Thinking That This Is A Good Idea'
Ahead of the 2024 presidential election, former President Donald Trump has made headlines with his latest trade policy proposal, promising hefty tariff on John Deere
Sell This Stock Before Election Day - Ad
Since the AI investing trend kicked off last year, the line between U.S. politics and the U.S. stock market has never been thinner. One 50-year Wall Street is stepping forward to warn of a dramatic market event that could rock the U.S. stock market before Election Day.
Massive Crypto Heist: Here's How Two Suspects Were Nabbed In $230M Theft
This week, federal prosecutors announced the arrest of two individuals accused of stealing $230 million in cryptocurrency.
Before you sign up for a store credit card, know what you're getting into
NEW YORK (AP) — When Mykail James was 19 and working a holiday job at Victoria's Secret, she took out a store credit card with a $2,000 credit line.
America's Secret New Currency (Buy Alert) - Ad
A new kind of money is coming to America. It's part of a huge shift quietly playing out in the financial system right now, with very little fanfare. It already has the backing of at least 470 banks, as well as the Federal Reserve and US Treasury.
Smartmatic, Newsmax Settle Defamation Lawsuit Over 2020 Election Claims
Smartmatic had zeroed in on 24 specific claims made on Newsmax that it considered defamatory.
What to stream: Coldplay, an unhinged Charlie Puth, 'Salem's Lot,' Sarah Paulson and NHL 25
Coldplay's 10th studio album and the American Music Awards celebrating their 50th anniversary are some of the new television, films, music and games near you.
Revolutionary Tech Alert: How Elon Musk Is Changing Lives - Ad
"Elon Musk's Neuralink just received FDA breakthrough status for a revolutionary device designed to restore vision to those who've lost it entirely. And the first human clinical trials have opened for recruitment. This is more than just a medical miracle -- it's a wealth-building opportunity. I believe Elon Musk's groundbreaking technology could unlock tremendous financial opportunities for early investors... And I've found a way for you to get in on the action." --Eric Fry
Home Depot Agrees To $2M Settlement In Customer Overcharging Lawsuit
Home Depot has agreed to a settlement of almost $2 million to resolve allegations that it overcharged customers at checkout.
Red Lobster exits Chapter 11 bankruptcy protection
Red Lobster, known for its affordable seafood and cheddary biscuits, has exited Chapter 11 bankruptcy protection.
Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad
The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.
Scaramucci: Donald Trump Is A 'Team Of One', Kamala Harris Has 'Done An Incredible Job'
Despite Kamala Harris starting late, she has made good ground in the presidential race, according to Anthony Scaramucci.
Mark Zuckerberg Says He Is Done Apologizing, Reveals One Of The Biggest Mistakes Of His Career
Meta CEO Mark Zuckerberg says he has grown tired of taking on too much ownership of problems beyond his or his company's control.
Red-Hot AI Stock "Disappearing" Soon? (Get In Now) - Ad
Right now, there's an AI stock on the verge of being snapped up by a giant company... And when it does, its price could go flying. The potential gains could be astronomical. You want to get in before that happens... Otherwise the opportunity could pass you by. Your window to buy in is right now...
How much will Southwest Airlines change to boost profits? Some details are emerging
DALLAS (AP) — Leaders of Southwest Airlines are set to explain how they plan to remodel the airline to change with consumer tastes -- and maybe keep their own jobs.
Motel 6 sold to Indian hotel operator for $525 million
The budget motel chain Motel 6 is being acquired by the parent company of Oyo, a hotel operator based in India.
Kamala Harris May Seize This Cutting-Edge Tech -- Act Now - Ad
A new technology (not AI) is powerful enough to save America $1.7 TRILLION in healthcare costs each year. Trump is rumored to use it personally... And Kamala Harris has threatened to have key patents on it seized. Whoever wins the election - it could cause a massive surge in demand... And send a tiny firm with key patents on this technology soaring. It's currently trading for only $7. But it likely won't stay this cheap for long.
Bitcoin ETF Surge In Pre-Market As King Crypto Hits $63,500
The cryptocurrency market has seen a significant surge in pre-market activity after Bitcoin (CRYPTO: BTC) reached a new high of $63,500.
Invitation Homes agrees to pay $48 million to settle claims it saddled tenants with hidden fees
The nation’s largest owner of single-family homes for rent has agreed to pay $48 million to settle claims by the Federal Trade Commission that it reaped millions of dollars via deceptive business practices, including forcing tenants to pay undisclosed fees on top of their monthly rent.
America Can't Afford a Harris Presidency - Ad
New research from Jim Rickards - former advisor to the CIA - reveals shocking predictions about an "Election Meltdown" coming this November. Jim's showing all American patriots why an "Election Meltdown" could crash stocks by 50%, lead to the final demise of the dollar, even cause violent riots in the streets.
Mark Zuckerberg Flaunts Watches Valued at a Cybertruck's Price
Mark Zuckerberg, CEO of Meta, has been seen sporting luxury watches that rival the cost of a Tesla Cybertruck.
Max Keiser Attacks Michael Saylor For Finding Fault With El Salvador's Bitcoin Strategy: 'You Owe Nayib Bukele An Apology'
Staunch Bitcoin (CRYPTO: BTC) advocate Max Keiser slammed MicroStrategy Inc. (NASDAQ:MSTR) co-founder Michael Saylor for casting aspersions on the Bitcoin strategy adopted
5 Stocks That Could Triple in a Week - Ad
What if I told you that I have a system that has detected when these tiny stocks are on the verge of exploding... And what if I told you my system has targeted 5 new stocks that could triple as early as next week? Pay just $5 for a full year of Stealth Trades before this deal disappears!
Asian Development Bank raises growth forecast for region, but warns of risks from trade sanctions
Developing economies in Asia are forecast to grow at a 5.0% annual pace this year, helped by a strong U.S. economy and surging demand for computer chips that power artificial intelligence, the Asian Development Bank said in a report Wednesday.
New US Single-Family Home Sales Fall From Prior Month — But Are Up From A Year Ago As Mortgage Rates Decline
U.S. home sales decline in August from July but rise from a year ago as mortgage rates fall. Sales down 4.7% from July, up 9.8% from 2023.
Financial Nightmare Coming After Election - Ad
In 2018, one independent research predicted Kamala Harris was on her way to becoming the president of the United States. "Frankly, she scares us to death... and she should scare you," they wrote. Which is why you need to check out their newest Kamala prediction immediately.
Titan submersible testimony to enter fourth day after panel hears of malfunction and discord
Another mission specialist who worked with the company that owned the Titan last year while on its way to the Titanic wreckage is scheduled to testify before a U.S. Coast Guard investigatory panel Friday.
Mark Cuban Says Trump's Lack Of Understanding Business Is 'Insane' — Slams 200% Tariff Threat On John Deere: 'Good Way To Destroy A Legendary American Company'
Ahead of the 2024 presidential election, former President Donald Trump has made headlines with his latest trade policy proposal, promising hefty tariffs on vehicles produced by alleged Chinese factories in Mexico.
50-Year Wall Street Legend: "Prepare for an Election Surprise" - Ad
During his 50 years on Wall Street, legendary stockpicker traded through 13 presidential elections. Today, he is stepping forward to warn of a critical market shift that could blindside millions of Americans before Election Day.
Japan's trade deficit grows while both imports, exports fall short of forecasts
TOKYO (AP) — Japan posted a trade deficit for a second straight month in August, the Finance Ministry said Wednesday, despite signs of sluggish consumer spending that weighed on imports.
Nvidia, T-Mobile US, Vivos Therapeutics, SoFi Technologies, Tesla: Why These 5 Stocks Are On Investors' Radars Today
NVDA, TMUS, VVOS, SOFI, TSLA are the top trending stocks on Wednesday.
Man Who Called Nvidia at $1.10 Says Buy This Now... - Ad
In 2004, a man predicted Nvidia's rise. Now, he says a new company, which IPO'd in 2023, could soar like Nvidia. It signed a major deal with Apple for its AI tech in iPhones and iMacs. Could it be the next trillion-dollar company? See why he believes it's among "The Next Magnificent Seven."
Anthony Scaramucci Explains How Kamala Harris Can Improve Her Poor Economic Polling: 'She Has To Get Out There And Do That'
Kamala Harris' Achilles' heel is the economy and she has to turn around things on that front to make a meaningful headway, says Scaramucci.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.